GRENKE AG

  • WKN: A161N3
  • ISIN: DE000A161N30
  • Land: Deutschland

Nachricht vom 16.05.2022 | 17:22

GRENKE AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

GRENKE AG
GRENKE AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
16.05.2022 / 17:22
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Notification of Major Holdings

1. Details of issuer
Name: GRENKE AG
Street: Neuer Markt 2
Postal code: 76532
City: Baden-Baden
Germany
Legal Entity Identifier (LEI): 529900BHRYZ464GFD289

2. Reason for notification
  Acquisition/disposal of shares with voting rights
  Acquisition/disposal of instruments
  Change of breakdown of voting rights
X Other reason:
Attribution due to controlling influence

3. Details of person subject to the notification obligation
Natural person (first name, surname): Moritz Grenke
Date of birth: 28 Sep 1985

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
GRENKE-Stiftung Verwaltungs GmbH, Baden-Baden

5. Date on which threshold was crossed or reached:
17 Dec 2018

6. Total positions
  % of voting rights attached to shares
(total of 7.a.)
% of voting rights through instruments
(total of 7.b.1 + 7.b.2)
Total of both in %
(7.a. + 7.b.)
Total number of voting rights pursuant to Sec. 41 WpHG
New 3.05 % 0.00 % 3.05 % 46,353,918
Previous notification 0 % 0 % 0 % /

7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN Absolute In %
  Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
DE000A161N30 5,200 1,408,500 0.01 % 3.04 %
Total 1,413,700 3.05 %

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
0 0.00 %
    Total 0 0.00 %

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
0 0.00 %
      Total 0 0.00 %

8. Information in relation to the person subject to the notification obligation
  Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)
Moritz Grenke % % %
GRENKE-Stiftung Verwaltungs GmbH 3.04 % % %

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights Proportion of instruments Total of both
% % %

10. Other explanatory remarks:
The notification is highly precautionary. Mr. Moritz Grenke has a controlling influence over GRENKE-Stiftung Verwaltungs GmbH pursuant to Sections 34 (1) No. 1, 35 WpHG. GRENKE-Stiftung Verwaltungs GmbH holds 1,408,500 shares in GRENKE AG in trust for the dependent (unincorporated) GRENKE-Stiftung, Baden Baden. 

Date
11 May 2022



16.05.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

Events im Fokus

Termine 2022

1./2. Juni 2022: Fachkonferenz Immobilien & Software | IT

13./14. Juli 2022: Fachkonferenz Beteiligungsgesellschaften & Consumer/Leisure

12./13. Oktober 2022: Fachkonferenz Finanzdienstleistungen/Technologie

News im Fokus

Deutsche Post AG: Bekanntgabe gemäß Art. 5 Abs. 1 der Verordnung (EU) Nr. 596/2014 i.V.m. Art. 2 Abs. 1 der Del. VO (EU) 2016/1052 der Kommission (in der jeweils gültigen Fassung)

28. Juni 2022, 11:00

Aktueller Webcast

Kinarus Therapeutics Holding AG

Replay KOL Webcast: Christian Pruente on wAMD and KIN001

27. Juni 2022

Aktuelle Research-Studie

STEICO SE

Original-Research: STEICO SE (von Montega AG): Kaufen

28. Juni 2022